ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 272 filers reported holding ALKERMES PLC in Q2 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,244,809 | +51.4% | 936,980 | +69.2% | 0.01% | +25.0% |
| Q2 2023 | $17,331,968 | +26.1% | 553,737 | +13.6% | 0.00% | +33.3% |
| Q1 2023 | $13,744,260 | +74.5% | 487,558 | +61.8% | 0.00% | +50.0% |
| Q4 2022 | $7,876,026 | -0.6% | 301,417 | -15.1% | 0.00% | 0.0% |
| Q3 2022 | $7,926,000 | +66.8% | 354,938 | +122.6% | 0.00% | +100.0% |
| Q2 2022 | $4,751,000 | +53.7% | 159,478 | +35.7% | 0.00% | – |
| Q1 2022 | $3,091,000 | -54.5% | 117,490 | -57.6% | 0.00% | -100.0% |
| Q2 2021 | $6,790,000 | -53.8% | 276,916 | -64.8% | 0.00% | -66.7% |
| Q1 2021 | $14,706,000 | -40.9% | 787,282 | -36.9% | 0.00% | +50.0% |
| Q4 2020 | $24,896,000 | +156.4% | 1,247,832 | +112.9% | 0.00% | 0.0% |
| Q3 2020 | $9,711,000 | +7.0% | 586,069 | +25.3% | 0.00% | 0.0% |
| Q2 2020 | $9,077,000 | +474.5% | 467,781 | +326.7% | 0.00% | – |
| Q1 2020 | $1,580,000 | -30.9% | 109,620 | -2.3% | 0.00% | -100.0% |
| Q4 2019 | $2,288,000 | +2.7% | 112,157 | -1.8% | 0.00% | – |
| Q3 2019 | $2,228,000 | -79.7% | 114,203 | -76.6% | 0.00% | -100.0% |
| Q2 2019 | $10,976,000 | +390.7% | 487,027 | +694.5% | 0.00% | 0.0% |
| Q1 2019 | $2,237,000 | -18.7% | 61,300 | -34.3% | 0.00% | -50.0% |
| Q4 2018 | $2,753,000 | -89.8% | 93,300 | -85.3% | 0.00% | -75.0% |
| Q3 2018 | $27,009,000 | +51.7% | 636,400 | +47.2% | 0.01% | +33.3% |
| Q2 2018 | $17,801,000 | -9.6% | 432,483 | +27.3% | 0.01% | -14.3% |
| Q1 2018 | $19,686,000 | +29.0% | 339,658 | +21.8% | 0.01% | +40.0% |
| Q4 2017 | $15,262,000 | +226.0% | 278,866 | +202.8% | 0.01% | +400.0% |
| Q3 2017 | $4,682,000 | -63.9% | 92,100 | -58.8% | 0.00% | -83.3% |
| Q2 2017 | $12,968,000 | +137.3% | 223,700 | +139.5% | 0.01% | +100.0% |
| Q1 2017 | $5,464,000 | -47.1% | 93,400 | -49.7% | 0.00% | -40.0% |
| Q4 2016 | $10,321,000 | +33.6% | 185,700 | +13.0% | 0.01% | +25.0% |
| Q3 2016 | $7,727,000 | -47.8% | 164,300 | -52.0% | 0.00% | -50.0% |
| Q2 2016 | $14,798,000 | +101.9% | 342,400 | +59.7% | 0.01% | +100.0% |
| Q1 2016 | $7,331,000 | -74.9% | 214,417 | -41.6% | 0.00% | -71.4% |
| Q4 2015 | $29,160,000 | +222.2% | 367,337 | +138.2% | 0.01% | +250.0% |
| Q3 2015 | $9,049,000 | -32.1% | 154,237 | -25.6% | 0.00% | -33.3% |
| Q2 2015 | $13,330,000 | -10.5% | 207,171 | -15.2% | 0.01% | -14.3% |
| Q1 2015 | $14,901,000 | -6.8% | 244,419 | -10.5% | 0.01% | +16.7% |
| Q4 2014 | $15,993,000 | +85.7% | 273,102 | +35.9% | 0.01% | +100.0% |
| Q3 2014 | $8,614,000 | -63.3% | 200,932 | -56.9% | 0.00% | -72.7% |
| Q2 2014 | $23,478,000 | +25.0% | 466,486 | +9.5% | 0.01% | +37.5% |
| Q1 2014 | $18,780,000 | +53.1% | 425,946 | +41.2% | 0.01% | +33.3% |
| Q4 2013 | $12,263,000 | +172.6% | 301,588 | +125.4% | 0.01% | +200.0% |
| Q3 2013 | $4,498,000 | -54.3% | 133,800 | -61.0% | 0.00% | -66.7% |
| Q2 2013 | $9,847,000 | – | 343,317 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |